These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8451122)

  • 21. The effect of ocular rigidity upon the characteristics of saccadic eye movements.
    Alhazmi M; Seidel D; Gray LS
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1251-8. PubMed ID: 24481265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visually stimulated saccadic eye movements in patients treated with lithium.
    Opgenoorth E; Kral G; Wolf R
    Acta Psychiatr Scand; 1986 Jan; 73(1):54-9. PubMed ID: 3962702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eye-hand coordination in essential tremor.
    Trillenberg P; Führer J; Sprenger A; Hagenow A; Kömpf D; Wenzelburger R; Deuschl G; Heide W; Helmchen C
    Mov Disord; 2006 Mar; 21(3):373-9. PubMed ID: 16211601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary (micro-)saccades: the influence of primary saccade end point and target eccentricity on the process of postsaccadic fixation.
    Ohl S; Brandt SA; Kliegl R
    Vision Res; 2011 Dec; 51(23-24):2340-7. PubMed ID: 21945994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual signals contribute to the coding of gaze direction.
    Blouin J; Amade N; Vercher JL; Teasdale N; Gauthier GM
    Exp Brain Res; 2002 Jun; 144(3):281-92. PubMed ID: 12021810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural mechanisms underlying target selection with saccadic eye movements.
    Schiller PH; Tehovnik EJ
    Prog Brain Res; 2005; 149():157-71. PubMed ID: 16226583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief intermittent light stimulation disrupts saccadic oculomotor control.
    Alvarez TL; Beck KD; Ciuffreda KJ; Chua FB; Daftari A; DeMarco RM; Bergen MT; Servatius RJ
    Ophthalmic Physiol Opt; 2008 Jul; 28(4):354-64. PubMed ID: 18565091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saccade-vergence interactions in macaques. I. Test of the omnipause Multiply Model.
    Busettini C; Mays LE
    J Neurophysiol; 2005 Oct; 94(4):2295-311. PubMed ID: 16160089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative analysis of the correlations between eye movements and neural activity in the pretectum.
    Missal M; Coimbra A; Lefèvre P; Olivier E
    Exp Brain Res; 2002 Apr; 143(3):373-82. PubMed ID: 11889515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The variable stimulus arc: logic-driven light-emitting diodes for instantaneous stimulation of saccadic refixational eye movements.
    Dell'Osso LF; Troost BT; Patterson D; Sacerio J
    Med Biol Eng; 1974 Nov; 12(6):773-7. PubMed ID: 4467005
    [No Abstract]   [Full Text] [Related]  

  • 31. Scopolamine and the sensory conditioning of hallucinations.
    Warburton DM; Wesnes K; Edwards J; Larrad D
    Neuropsychobiology; 1985; 14(4):198-202. PubMed ID: 3835496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saccadic eye movements in determination of the residual effects of flunitrazepam.
    Salonen M; Aaltonen L; Aantaa E; Kanto J
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):303-5. PubMed ID: 3799209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaesthesia and saccadic eye movements.
    Khan OA; Taylor SR; Jones JG
    Anaesthesia; 2000 Sep; 55(9):877-82. PubMed ID: 10947751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saccades--random or constant stimuli and predictive adaptability.
    Takemori S; Ida M
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(6):310-7. PubMed ID: 6504513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Confusional syndrome and arterial hypertension after instillation of scopolamine].
    Sirbat D; Trechot P; Duc M; George JL; Netter P
    Presse Med; 1986 Dec; 15(44):2212. PubMed ID: 2949247
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of scopolamine on balance of oculomotor muscles].
    ZAHN K
    Cesk Oftalmol; 1952 Dec; 8(6):367-72. PubMed ID: 13009781
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantification of ocular dominance for better management of eye disease].
    Chaumillon R; Alahyane N; Senot P; Vergne J; Lemoine C; Doré-Mazars K; Blouin J; Vergilino-Perez D; Guillaume A
    J Fr Ophtalmol; 2015 Apr; 38(4):322-32. PubMed ID: 25842149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular flutter in vidarabine toxicity.
    Gizzi M; Rudolph S; Perakis A
    Am J Ophthalmol; 1990 Jan; 109(1):105. PubMed ID: 2297021
    [No Abstract]   [Full Text] [Related]  

  • 39. Belladonna alkaloids.
    Whiteman JA; Edeen J
    Mil Med; 1990 Apr; 155(4):A17. PubMed ID: 2110327
    [No Abstract]   [Full Text] [Related]  

  • 40. Objective and Subjective Evaluation of Saccadic Eye Movements in Healthy Children and Children with Neurodevelopmental Disorders: A Pilot Study.
    Bilbao C; Piñero DP
    Vision (Basel); 2021 Jun; 5(2):. PubMed ID: 34200241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.